AMPA

The AMPA receptor (named after α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, the compound used to identify it) is the most abundant excitatory receptor in the human brain. It belongs to the ionotropic glutamate receptor family — meaning it is both a receptor and an ion channel built into one structure — and it responds to glutamate, the brain's primary excitatory neurotransmitter.

AMPA receptors sit at synapses throughout the central nervous system, alongside their close relative the NMDA. While NMDA receptors act as slower, coincidence-detecting switches, AMPA receptors handle the fast, moment-to-moment business of excitatory signalling: most of what neurons communicate to each other passes through them.

How it works · its role

When glutamate is released from one neuron and binds to an AMPA receptor on the receiving cell, the receptor's ion channel opens in milliseconds, allowing sodium ions to rush in and potassium to flow out. This rapid charge shift depolarises the membrane — the electrical event that propagates a signal forward.

AMPA receptors are also central to synaptic plasticity, the process by which connections between neurons strengthen or weaken with use. During long-term potentiation — the cellular basis of learning and memory — more AMPA receptors are physically inserted into the synapse, amplifying its sensitivity. Conversely, they can be withdrawn to weaken a connection. The brain is constantly shuffling AMPA receptors in and out of synapses as experience reshapes it.

Relevance to substances & effects

Several psychoactive drug classes intersect with AMPA signalling, often indirectly. Dissociatives such as ketamine and phencyclidine (PCP) primarily block NMDA receptors, but this blockade shifts the balance of glutamate activity, increasing the relative contribution of AMPA receptors. The resulting surge in AMPA-driven signalling — particularly in prefrontal circuits — is thought to underlie ketamine's rapid antidepressant effects, a mechanism distinct from classical antidepressants.

Alcohol and other central nervous system depressants broadly inhibit excitatory glutamate transmission, dampening AMPA receptor activity alongside NMDA receptors. This contributes to the sedation, cognitive blunting, and motor impairment they produce.

A class of compounds called ampakines — positive allosteric modulators that prolong AMPA receptor opening without directly activating it — has attracted research interest as potential cognitive enhancers. Some have been investigated in clinical contexts for conditions involving impaired arousal or memory, though none are in widespread use.

Because AMPA receptors are so fundamental to excitatory transmission, anything that significantly shifts their activity — up or down — can have wide-ranging effects on alertness, memory encoding, mood, and perception.